M. You

发表

Small molecule antagonists of the bradykinin B1 receptor.

N. Sigal, M. Webb, J. Baldwin, 1999, Immunopharmacology.

Enhancement of Oral Bioavailability of 20(S)-Ginsenoside Rh2 through Improved Understanding of Its Absorption and Efflux Mechanisms

Taijun Yin, Song Gao, M. Hu, 2011, Drug Metabolism and Disposition.

Validated LC-MS/MS method for the determination of maackiain and its sulfate and glucuronide in blood: application to pharmacokinetic and disposition studies.

Taijun Yin, Song Gao, M. Hu, 2011, Journal of pharmaceutical and biomedical analysis.

Imidazolylpyrimidine based CXCR2 chemokine receptor antagonists.

D. Auld, J. van der Louw, M. Webb, 2006, Bioorganic & medicinal chemistry letters.

Bioactivity and Bioavailability of Ginsenosides are Dependent on the Glycosidase Activities of the A/J Mouse Intestinal Microbiome Defined by Pyrosequencing

R. Gibbs, J. Petrosino, Zhi-Hong Jiang, 2012, Pharmaceutical Research.

Enhanced oral absorption of 20(S)-protopanaxadiol by self-assembled liquid crystalline nanoparticles containing piperine: in vitro and in vivo studies

S. Li, Zhenhai Zhang, Xiao-Bin Jia, 2013, International journal of nanomedicine.

Pharmacokinetic and Metabolic Profiling of Key Active Components of Dietary Supplement Magnolia officinalis Extract for Prevention against Oral Carcinoma.

Li Li, R. Singh, Taijun Yin, 2020, Journal of agricultural and food chemistry.

Developing an activity and absorption-based quality control platform for Chinese traditional medicine: Application to Zeng-Sheng-Ping(Antitumor B).

Taijun Yin, Song Gao, M. You, 2015, Journal of ethnopharmacology.

Biopharmaceutical and pharmacokinetic characterization of matrine as determined by a sensitive and robust UPLC-MS/MS method.

Taijun Yin, Song Gao, M. You, 2010, Journal of pharmaceutical and biomedical analysis.

Pharmacokinetic Basis for Using Saliva Matrine Concentrations as a Clinical Compliance Monitoring in Antitumor B Chemoprevention Trials in Humans

Lenora A McWilliams, Lei Wu, R. Singh, 2022, Cancers.

Inhibition of P-Glycoprotein Leads to Improved Oral Bioavailability of Compound K, an Anticancer Metabolite of Red Ginseng Extract Produced by Gut Microflora

Jing-Rong Wang, Taijun Yin, Song Gao, 2012, Drug Metabolism and Disposition.

Pharmacokinetic Characterization and Bioavailability Barrier for the Key Active Components of Botanical Drug Antitumor B (ATB) in Mice for Chemoprevention of Oral Cancer.

Peiying Yang, R. Singh, Taijun Yin, 2021, Journal of natural products.

2-Benzimidazolyl-9-(chroman-4-yl)-purinone derivatives as JAK3 inhibitors.

David J Diller, Maria L Webb, M. Webb, 2009, Bioorganic & medicinal chemistry letters.

Bioactivity and Bioavailability of Ginsenosides are Dependent on the Glycosidase Activities of the A/J Mouse Intestinal Microbiome Defined by Pyrosequencing

R. Gibbs, J. Petrosino, Taijun Yin, 2013, Pharmaceutical Research.